ALLIANCEBERNSTEIN L.P. - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 73 filers reported holding IMMUNE DESIGN CORP in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q1 2019$67,000
+272.2%
11,500
-17.9%
0.00%
Q4 2018$18,000
-67.9%
14,000
-13.6%
0.00%
Q3 2018$56,000
-24.3%
16,2000.0%0.00%
Q2 2018$74,000
+89.7%
16,200
+37.3%
0.00%
Q1 2018$39,000
-15.2%
11,8000.0%0.00%
Q4 2017$46,000
-63.2%
11,800
-2.5%
0.00%
Q3 2017$125,000
+5.9%
12,1000.0%0.00%
Q2 2017$118,000
+293.3%
12,100
+764.3%
0.00%
Q1 2015$30,0001,4000.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q3 2018
NameSharesValueWeighting ↓
COLUMN GROUP L P 3,161,942$66,749,000100.00%
ProQuest Associates IV LLC 2,414,040$50,960,00016.62%
Iguana Healthcare Management, LLC 100,000$2,111,0000.89%
Cormorant Asset Management, LP 119,000$2,512,0000.39%
SPHERA FUNDS MANAGEMENT LTD. 129,440$2,732,0000.28%
HAMILTON LANE ADVISORS LLC 17,312$365,0000.17%
Eventide Asset Management 81,957$1,730,0000.13%
RS INVESTMENT MANAGEMENT CO LLC 522,872$11,038,0000.10%
SECTORAL ASSET MANAGEMENT INC 67,127$1,417,0000.05%
Focused Wealth Management, Inc 3,909$83,0000.05%
View complete list of IMMUNE DESIGN CORP shareholders